Nippon India Pharma Fund Growth+1.44%

55.72%
1 Year Return
Equity
Sectoral/Thematic
5.0star
6M
1Y
3Y
5Y
All

Fund Details

Nippon India Pharma Fund Growth

RiskHigh
Min SIP Amount₹100
Expense Ratio2.19%
NAV226.60 (27 Oct 2020)
Fund Started05 Jun 2004
Fund Size3,911 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Nippon India Pharma Fund Growth
55.7%
19.6%
7.7%
21.0%
Category Average
57.5%
15.9%
5.1%
-
Rank within category
6
1
1
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    For how many years?
    1 Year
    3 Years
    5 Years
    Estimated Value
    as per Historical Returns
    0
    with 55.7% annual returns

    Comparison

    Data not available
    Pros
    1. Age is more than 10 years
    2. Risk is lower compared to the benchmark
    3. 1Y Returns are higher than the benchmark
    4. 3Y Returns are higher than the benchmark
    5. 5Y Returns are higher than the benchmark
    6. Age is more than 10 years
    7. 3Y Returns are higher than the category average returns
    8. 5Y Returns are higher than the category average returns
    9. 10Y Returns are higher than the category average returns
    Cons
    1. Risk-adjusted returns are lower compared to the category
    2. Higher expense ratio
    3. 10Y Returns are lower than the benchmark
    4. Risk-adjusted returns are lower compared to the category
    5. Higher expense ratio - 2.19%

    Top Holdings

    NameSectorInstrument% Assets
    Lupin Ltd.HealthcareEquity10.3%
    Aurobindo Pharma Ltd.HealthcareEquity10.0%
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity9.7%
    Dr. Reddy's Laboratories Ltd.HealthcareEquity9.6%
    Divi's Laboratories Ltd.HealthcareEquity9.3%
    Cipla Ltd.HealthcareEquity9.3%
    Thyrocare Technologies Ltd.HealthcareEquity5.5%
    Fortis Healthcare (India) LtdHealthcareEquity5.0%
    Cadila Healthcare Ltd.HealthcareEquity4.0%
    Sanofi India Ltd.HealthcareEquity3.9%
    See All

    Fund Managers

    addSailesh Raj Bhan
    Education
    Mr. Bhan is an MBA (Finance) and CFA.
    Experience
    Mr. Sailesh Raj Bhan has about 19 years experience in equity research and fund management, with over 10 years at Reliance Nippon Life Asset Management Limited (formerly Reliance Capital Asset Management Limited). He manages diversified equity schemes like Reliance Equity Opportunities Fund (the largest Flexicap Scheme in India with assets of USD 800 million) since its inception in 2005 and Reliance Top200 Fund (a large cap diversified equity fund) since its inception in 2007. In addition, for over 9 years, he has been managing two specialized sector funds - Reliance Pharma Sector Fund (the largest pharma sector fund in India) and Reliance Media and Entertainment Fund.
    Funds Managed

    Nippon India Pharma Fund Growth Details

    Nippon India Pharma Fund Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 05 Jun 2004. Sailesh Raj Bhan is the Current Fund Manager of Nippon India Pharma Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹3,911 Cr and the Latest NAV as of 27 Oct 2020 is ₹226.60.

    The Nippon India Pharma Fund Growth is rated High risk. Minimum SIP Investment is set to 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 month.

    Investment Objective

    The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

    Tax Implications

    Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

    Scheme Information Document(SID)

    ₹5000
    Min for First Investment
    ₹1000
    Min for Second Investment
    Exit load of 1% if redeemed within 1 month.
    Exit Load

    Compare Funds

    Nippon India Pharma Fund Growth
    VS
    search

    About Nippon India Mutual Fund

    Address
    Corporate Office : Reliance Centre, 7th Floor South Wing, OFf Western Express Highway, Santacruz(E) Mumbai-400055
    Phone
    022-33031000/30301111
    Launch Date
    30 Jun 1995
    Nippon India Mutual Fund
    Asset Management Company
    Custodian
    Deutsche Bank
    Registrar & Transfer Agent
    KFin Tech
    Address
    Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
    Similar Funds
    Data not available